We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy Soaring Chewy Stock Before Q3 Earnings as E-Commerce Play?
Read MoreHide Full Article
Chewy (CHWY - Free Report) is an e-commerce pet store that has expanded into telehealth and bolstered its pet medication offerings. The company’s shares have climbed over 25% in the last month and they hit new records on December 1. This could mean that investors are high on the stock heading into the release of its third quarter FY20 financial results on Tuesday, December 8.
Pet-Commerce
Chewy started in 2011 and went public in June 2019. The e-commerce-focused pet store, which offers relatively speedy delivery, sells pet food, supplies, treats, medications, and more for a wide variety of animals. CHWY has found a solid niche within a crowded digital commerce world dominated by giants such as Amazon (AMZN - Free Report) , Target (TGT - Free Report) , Walmart (WMT - Free Report) , and others.
CHWY has also expanded its reach more recently into new areas that could prove successful. The company announced at the end of October its plans to roll out its new telehealth service, dubbed “Connect With a Vet,” nationwide. Chewy said at the time that it was available in over 35 states. It is worth noting that the service is currently available “exclusively and free of charge” to its vital Autoship customers.
Chewy’s telehealth offering could prove to be a hit during the pandemic and beyond, in a world where Teladoc (TDOC - Free Report) and others are gaining steam. Along the same lines, the firm announced on November 12 that it was expanding its pharmacy unit to “offer compounded medications that are customized to the specific needs of pets.”
What Else?
Chewy’s offerings have are clearly compelling in our modern retail world. The firm closed Q2 with 16.6 million active customers, up 38% from the year-ago period. Meanwhile, its revenue surged 47% in both the first and second quarters. And investors must continue to keep an eye on CHWY’s Autoship business, which accounted for roughly 70% of total revenue.
Looking ahead, Zacks estimates call for CHWY’s Q3 revenue to climb 40% to help trim its adjusted loss from -$0.20 in the prior-year quarter to -$0.15 a share. CHWY’s full-year fiscal 2020 revenue is projected to jump by 41% to come in at $6.84 billion, with FY21 projected to climb 23% higher to reach $8.43 billion. These would both come on top of FY19’s 37% revenue growth.
Chewy is projected to extend its loss this year from -$0.29 to -$0.40 a share, as it spends on its own growth. It is then expected to shrink its bottom line loss to -$0.12 per share in FY21. Investors should note that CHWY’s positive earnings revisions help it land a Zacks Rank #2 (Buy) right now. The stock also sports an “A” grade for Growth and CHWY topped our Q2 EPS estimate by roughly 50%.
Moving on, the nearby chart highlights CHWY’s strong run over the past 12 months, with the stock up 220%. This helps it edged out fellow stay-at-home standout Peloton (PTON - Free Report) . CHWY has also climbed over 25% in the last month, following its two significant announcements, and it hit new highs of over $78 per share on Tuesday.
CHWY trades at 3.8X forward 12-months sales. This marks a huge discount to fellow niche e-commerce firm Etsy’s (ETSY - Free Report) 11.5X, Peloton’s 7.8X, and comes right in line with Amazon.
Bottom Line
Playing a stock for near-term gains around earnings is risky, especially given Chewy’s recent run. That said, longer-term investors might want to take a chance on the e-commerce pet store as a continued coronavirus play and a bet on the long-term expansion of digital commerce and delivery, which are the future and still have miles of room to grow.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Buy Soaring Chewy Stock Before Q3 Earnings as E-Commerce Play?
Chewy (CHWY - Free Report) is an e-commerce pet store that has expanded into telehealth and bolstered its pet medication offerings. The company’s shares have climbed over 25% in the last month and they hit new records on December 1. This could mean that investors are high on the stock heading into the release of its third quarter FY20 financial results on Tuesday, December 8.
Pet-Commerce
Chewy started in 2011 and went public in June 2019. The e-commerce-focused pet store, which offers relatively speedy delivery, sells pet food, supplies, treats, medications, and more for a wide variety of animals. CHWY has found a solid niche within a crowded digital commerce world dominated by giants such as Amazon (AMZN - Free Report) , Target (TGT - Free Report) , Walmart (WMT - Free Report) , and others.
CHWY has also expanded its reach more recently into new areas that could prove successful. The company announced at the end of October its plans to roll out its new telehealth service, dubbed “Connect With a Vet,” nationwide. Chewy said at the time that it was available in over 35 states. It is worth noting that the service is currently available “exclusively and free of charge” to its vital Autoship customers.
Chewy’s telehealth offering could prove to be a hit during the pandemic and beyond, in a world where Teladoc (TDOC - Free Report) and others are gaining steam. Along the same lines, the firm announced on November 12 that it was expanding its pharmacy unit to “offer compounded medications that are customized to the specific needs of pets.”
What Else?
Chewy’s offerings have are clearly compelling in our modern retail world. The firm closed Q2 with 16.6 million active customers, up 38% from the year-ago period. Meanwhile, its revenue surged 47% in both the first and second quarters. And investors must continue to keep an eye on CHWY’s Autoship business, which accounted for roughly 70% of total revenue.
Looking ahead, Zacks estimates call for CHWY’s Q3 revenue to climb 40% to help trim its adjusted loss from -$0.20 in the prior-year quarter to -$0.15 a share. CHWY’s full-year fiscal 2020 revenue is projected to jump by 41% to come in at $6.84 billion, with FY21 projected to climb 23% higher to reach $8.43 billion. These would both come on top of FY19’s 37% revenue growth.
Chewy is projected to extend its loss this year from -$0.29 to -$0.40 a share, as it spends on its own growth. It is then expected to shrink its bottom line loss to -$0.12 per share in FY21. Investors should note that CHWY’s positive earnings revisions help it land a Zacks Rank #2 (Buy) right now. The stock also sports an “A” grade for Growth and CHWY topped our Q2 EPS estimate by roughly 50%.
Moving on, the nearby chart highlights CHWY’s strong run over the past 12 months, with the stock up 220%. This helps it edged out fellow stay-at-home standout Peloton (PTON - Free Report) . CHWY has also climbed over 25% in the last month, following its two significant announcements, and it hit new highs of over $78 per share on Tuesday.
CHWY trades at 3.8X forward 12-months sales. This marks a huge discount to fellow niche e-commerce firm Etsy’s (ETSY - Free Report) 11.5X, Peloton’s 7.8X, and comes right in line with Amazon.
Bottom Line
Playing a stock for near-term gains around earnings is risky, especially given Chewy’s recent run. That said, longer-term investors might want to take a chance on the e-commerce pet store as a continued coronavirus play and a bet on the long-term expansion of digital commerce and delivery, which are the future and still have miles of room to grow.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>